US Bancorp’s iShares Biotechnology ETF IBB Stock Holding History

US Bancorp’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.01M	Sell	15,827 -422	-3%	-$72.5K	﹤0.01%	781
2026 Q1	$2.74M	Buy	16,249 +1,792	+12%	+$306K	﹤0.01%	775
2025 Q4	$2.44M	Sell	14,457 -725	-5%	-$118K	﹤0.01%	815
2025 Q3	$2.19M	Buy	15,182 +112	+0.7%	+$15.3K	﹤0.01%	844
2025 Q2	$1.91M	Sell	15,070 -136	-0.9%	-$16.7K	﹤0.01%	872
2025 Q1	$1.94M	Buy	15,206 +1,604	+12%	+$217K	﹤0.01%	863
2024 Q4	$1.8M	Sell	13,602 -426	-3%	-$59.9K	﹤0.01%	901
2024 Q3	$2.04M	Buy	14,028 +378	+3%	+$54.7K	﹤0.01%	866
2024 Q2	$1.87M	Sell	13,650 -1,056	-7%	-$141K	﹤0.01%	865
2024 Q1	$2.02M	Sell	14,706 -543	-4%	-$74.2K	﹤0.01%	842
2023 Q4	$2.07M	Sell	15,249 -1,238	-8%	-$151K	﹤0.01%	815
2023 Q3	$2.02M	Sell	16,487 -951	-5%	-$121K	﹤0.01%	793
2023 Q2	$2.21M	Sell	17,438 -412	-2%	-$53.5K	﹤0.01%	761
2023 Q1	$2.31M	Sell	17,850 -4,416	-20%	-$578K	﹤0.01%	760
2022 Q4	$2.92M	Buy	22,266 +8,104	+57%	+$1.05M	0.01%	683
2022 Q3	$1.66M	Sell	14,162 -5,172	-27%	-$642K	﹤0.01%	846
2022 Q2	$2.27M	Sell	19,334 -13,009	-40%	-$1.54M	﹤0.01%	768
2022 Q1	$4.21M	Buy	32,343 +11,737	+57%	+$1.53M	0.01%	612
2021 Q4	$3.15M	Buy	20,606 +314	+2%	+$48.6K	0.01%	743
2021 Q3	$3.28M	Sell	20,292 -84	-0.4%	-$14.1K	0.01%	696
2021 Q2	$3.33M	Sell	20,376 -119	-0.6%	-$18.3K	0.01%	704
2021 Q1	$3.09M	Sell	20,495 -254	-1%	-$40.3K	0.01%	690
2020 Q4	$3.14M	Buy	20,749 +1,413	+7%	+$202K	0.01%	653
2020 Q3	$2.62M	Sell	19,336 -500	-3%	-$67.8K	0.01%	662
2020 Q2	$2.71M	Buy	19,836 +21	+0.1%	+$2.68K	0.01%	632
2020 Q1	$2.13M	Buy	19,815 +1,589	+9%	+$183K	0.01%	650
2019 Q4	$2.2M	Buy	18,226 +1,696	+10%	+$189K	0.01%	744
2019 Q3	$1.64M	Sell	16,530 -415	-2%	-$43.4K	﹤0.01%	826
2019 Q2	$1.85M	Sell	16,945 -13,024	-43%	-$1.39M	0.01%	816
2019 Q1	$3.35M	Sell	29,969 -3,418	-10%	-$375K	0.01%	598
2018 Q4	$3.22M	Sell	33,387 -630	-2%	-$66.9K	0.01%	574
2018 Q3	$4.15M	Buy	34,017 +1,422	+4%	+$167K	0.01%	562
2018 Q2	$3.58M	Buy	32,595 +2,032	+7%	+$217K	0.01%	598
2018 Q1	$3.26M	Buy	30,563 +2,747	+10%	+$305K	0.01%	622
2017 Q4	$2.97M	Buy	27,816 +1,896	+7%	+$203K	0.01%	657
2017 Q3	$2.88M	Buy	25,920 +468	+2%	+$50K	0.01%	652
2017 Q2	$2.63M	Buy	25,452 +921	+4%	+$90.7K	0.01%	666
2017 Q1	$2.4M	Sell	24,531 -3,009	-11%	-$288K	0.01%	698
2016 Q4	$2.44M	Buy	27,540 +6,417	+30%	+$584K	0.01%	685
2016 Q3	$2.04M	Buy	21,123 +5,193	+33%	+$494K	0.01%	729
2016 Q2	$1.37M	Sell	15,930 -708	-4%	-$63.5K	0.01%	854
2016 Q1	$1.45M	Buy	16,638 +9	+0.1%	+$805	0.01%	812
2015 Q4	$1.88M	Sell	16,629 -192	-1%	-$20.8K	0.01%	719
2015 Q3	$1.7M	Sell	16,821 -4,626	-22%	-$555K	0.01%	750
2015 Q2	$2.64M	Buy	21,447 +1,677	+8%	+$201K	0.01%	641
2015 Q1	$2.26M	Buy	19,770 +3,249	+20%	+$358K	0.01%	679
2014 Q4	$1.67M	Hold	16,521	–	–	0.01%	773
2014 Q3	$1.51M	Buy	16,521 +510	+3%	+$44.8K	0.01%	802
2014 Q2	$1.37M	Buy	16,011 +1,299	+9%	+$102K	0.01%	851
2014 Q1	$1.16M	Buy	14,712 +5,883	+67%	+$490K	﹤0.01%	900
2013 Q4	$668K	Buy	8,829 +2,433	+38%	+$173K	﹤0.01%	1147
2013 Q3	$447K	Buy	6,396 +312	+5%	+$20.4K	﹤0.01%	1310
2013 Q2	$353K	Buy	+6,084	New	+$352K	﹤0.01%	1351

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

US Bancorp's IBB Position: Q2 2026 in Review

US Bancorp reduced its iShares Biotechnology ETF (IBB) stake by 2.6% in Q2 2026, selling an estimated $72.5K and leaving 15,827 shares worth $3.01M. The position accounts for ﹤0.01% of the portfolio, ranked #781.

US Bancorp first reported a position in IBB in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.21M in Q1 2022. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

US Bancorp held 15,827 shares of iShares Biotechnology ETF worth $3.01M as of Q2 2026.
US Bancorp sold 422 iShares Biotechnology ETF shares in Q2 2026, an estimated $72.5K.
iShares Biotechnology ETF made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #781 holding.
US Bancorp first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 53 quarters since.
US Bancorp's iShares Biotechnology ETF position peaked at $4.21M in Q1 2022.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.